Revuz J - Search Results

1

Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis.

Valeyrie-Allanore L, Wolkenstein P, Brochard L, Ortonne N, Maître B, Revuz J, Bagot M, Roujeau JC. Valeyrie-Allanore L, et al. Among authors: revuz j. Br J Dermatol. 2010 Oct;163(4):847-53. doi: 10.1111/j.1365-2133.2010.09863.x. Br J Dermatol. 2010. PMID: 20500799 Clinical Trial.

2

Prognostic value of histologic features of toxic epidermal necrolysis.

Valeyrie-Allanore L, Bastuji-Garin S, Guégan S, Ortonne N, Bagot M, Roujeau JC, Revuz JE, Wechsler J, Wolkenstein P. Valeyrie-Allanore L, et al. Among authors: revuz je. J Am Acad Dermatol. 2013 Feb;68(2):e29-35. doi: 10.1016/j.jaad.2011.10.007. Epub 2011 Nov 16. J Am Acad Dermatol. 2013. PMID: 22088428

3

Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis.

Guégan S, Bastuji-Garin S, Poszepczynska-Guigné E, Roujeau JC, Revuz J. Guégan S, et al. Among authors: revuz j. J Invest Dermatol. 2006 Feb;126(2):272-6. doi: 10.1038/sj.jid.5700068. J Invest Dermatol. 2006. PMID: 16374461 Free article.

4

Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression.

Bachot N, Revuz J, Roujeau JC. Bachot N, et al. Among authors: revuz j. Arch Dermatol. 2003 Jan;139(1):33-6. doi: 10.1001/archderm.139.1.33. Arch Dermatol. 2003. PMID: 12533161 Clinical Trial.

5

Advances in toxic epidermal necrolysis.

Revuz JE, Roujeau JC. Revuz JE, et al. Semin Cutan Med Surg. 1996 Dec;15(4):258-66. doi: 10.1016/s1085-5629(96)80039-3. Semin Cutan Med Surg. 1996. PMID: 9069594 Review.

6

Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus.

Saiag P, Caumes E, Chosidow O, Revuz J, Roujeau JC. Saiag P, et al. Among authors: revuz j. J Am Acad Dermatol. 1992 Apr;26(4):567-74. doi: 10.1016/0190-9622(92)70082-q. J Am Acad Dermatol. 1992. PMID: 1597543

7

Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes.

Assier H, Bastuji-Garin S, Revuz J, Roujeau JC. Assier H, et al. Among authors: revuz j. Arch Dermatol. 1995 May;131(5):539-43. Arch Dermatol. 1995. PMID: 7741539

8

Metabolic predisposition to cutaneous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants.

Wolkenstein P, Charue D, Laurent P, Revuz J, Roujeau JC, Bagot M. Wolkenstein P, et al. Among authors: revuz j. Arch Dermatol. 1995 May;131(5):544-51. Arch Dermatol. 1995. PMID: 7741540

9

Characteristics of toxic epidermal necrolysis in patients undergoing long-term glucocorticoid therapy.

Guibal F, Bastuji-Garin S, Chosidow O, Saiag P, Revuz J, Roujeau JC. Guibal F, et al. Among authors: revuz j. Arch Dermatol. 1995 Jun;131(6):669-72. Arch Dermatol. 1995. PMID: 7778917

10

Increased serum and blister fluid levels of creatine kinase in patients with toxic epidermal necrolysis.

Caux F, Chosidow O, Philippon C, Roujeau JC, Revuz J. Caux F, et al. Among authors: revuz j. Br J Dermatol. 1994 Mar;130(3):337-41. doi: 10.1111/j.1365-2133.1994.tb02930.x. Br J Dermatol. 1994. PMID: 8148275

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

520 results

Search Page

Filters